MapLight Therapeutics is a biopharma company that offers a platform designed to discover and develop therapeutics for brain disorders.
MapLight Therapeutics has raised $372.5M in total funding. The most recent round was Series D. The last funding was announced in July 2025.
MapLight Therapeutics's investors include Blue Owl, Sanofi, Novo Holdings, 5AM Ventures, T. Rowe Price.
MapLight Therapeutics is headquartered in Palo Alto, United States.
MapLight Therapeutics is a biopharma company that offers a platform designed to discover and develop therapeutics for brain disorders.
MapLight Therapeutics is at the Series D stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"MapLight Therapeutics — Funding & Investors." VCBacked, July 28, 2025, https://www.vcbacked.co/company/maplight-therapeutics. Accessed July 31, 2026.
VCBacked. (2025). MapLight Therapeutics — Funding & Investors. Retrieved July 31, 2026, from https://www.vcbacked.co/company/maplight-therapeutics
{{cite web |title=MapLight Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/maplight-therapeutics |website=VCBacked |access-date=July 31, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated